{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T11:43:15Z","timestamp":1784547795315,"version":"3.55.0"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["High Blood Press Cardiovasc Prev"],"DOI":"10.1007\/s40292-026-00786-5","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T08:48:09Z","timestamp":1773823689000},"page":"351-356","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Lack of regional and whole body sympathetic normalization during antihypertensive drug treatment: a potential link for the residual risk"],"prefix":"10.1007","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1922-6547","authenticated-orcid":false,"given":"Guido","family":"Grassi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Facchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Jelakovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesare","family":"Cuspidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,18]]},"reference":[{"key":"786_CR1","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1161\/Hypertensionaha.124.24429","volume":"82","author":"F Quarti-Trevano","year":"2025","unstructured":"Quarti-Trevano F, Seravalle G, Facchetti R, Tsioufis K, Dimitriadis K, Manta E, et al. Failure of antihypertensive treatment to restore normal sympathetic activity. Hypertension. 2025;82:1024\u201334. https:\/\/doi.org\/10.1161\/Hypertensionaha.124.24429.","journal-title":"Hypertension"},{"key":"786_CR2","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s10286-010-0065-7","volume":"20","author":"DS Goldstein","year":"2010","unstructured":"Goldstein DS. Catecholamines 101. Clin Auton Res. 2010;20:331\u201352. https:\/\/doi.org\/10.1007\/s10286-010-0065-7.","journal-title":"Clin Auton Res"},{"key":"786_CR3","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1097\/00004872-199816120-00012","volume":"16","author":"G Grassi","year":"1998","unstructured":"Grassi G, Turri C, Dell\u2019Oro R, Stella ML, Bolla GB, Mancia G. Effect of chronic angiotensin converting enzyme inhibition on sympathetic nerve traffic and baroreflex control of the circulation in essential hypertension. J Hypertens. 1998;16:1789\u201396. https:\/\/doi.org\/10.1097\/00004872-199816120-00012.","journal-title":"J Hypertens"},{"key":"786_CR4","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1161\/01.HYP.0000058003.27729.5A","volume":"41","author":"G Grassi","year":"2003","unstructured":"Grassi G, Seravalle G, Turri C, Bolla GB, Mancia G. Short- versus long-term effects of different dihydropyridines on sympathetic and baroreflex function in hypertension. Hypertension. 2003;41:558\u201362. https:\/\/doi.org\/10.1161\/01.HYP.0000058003.27729.5A.","journal-title":"Hypertension"},{"key":"786_CR5","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1097\/00004872-200309000-00027","volume":"21","author":"G Grassi","year":"2003","unstructured":"Grassi G, Seravalle G, Dell\u2019Oro R, Quarti-Trevano F, Bombelli M, Scopelliti F, et al. Comparative effects of candesartan and hydrochlorothiazide on blood pressure, insulin sensitivity and sympathetic drive in obese hypertensive individuals: results of the CROSS study. J Hypertens. 2003;21:1761\u20139. https:\/\/doi.org\/10.1097\/00004872-200309000-00027.","journal-title":"J Hypertens"},{"key":"786_CR6","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.jash.2016.01.006","volume":"10","author":"G Seravalle","year":"2016","unstructured":"Seravalle G, Brambilla G, Prata Pizzalla D, Casati A, Riva M, Cuspidi C, et al. Differential effects of enalapril-felodipine versus enalapril-lercanidipine combination drug treatment on sympathetic nerve traffic and metabolic profile in obesity-related hypertension. J Am Soc Hypertens. 2016;10:244\u201351. https:\/\/doi.org\/10.1016\/j.jash.2016.01.006.","journal-title":"J Am Soc Hypertens"},{"key":"786_CR7","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s40292-014-0056-1","volume":"21","author":"G Seravalle","year":"2014","unstructured":"Seravalle G, Mancia G, Grassi G. Role of the sympathetic nervous system in hypertension and hypertension-related cardiovascular disease. High Blood Press Cardiovasc Prev. 2014;21:89\u2013105. https:\/\/doi.org\/10.1007\/s40292-014-0056-1.","journal-title":"High Blood Press Cardiovasc Prev"},{"key":"786_CR8","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1080\/10826079608006322","volume":"19","author":"S Javidan","year":"1996","unstructured":"Javidan S, Cwik MJ. Determination of catecholamines in human plasma by HPLC with electrochemical detection. J Liq Chromatogr Relat Technol. 1996;19:1339\u201348. https:\/\/doi.org\/10.1080\/10826079608006322.","journal-title":"J Liq Chromatogr Relat Technol"},{"key":"786_CR9","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s40292-025-00716-x","volume":"32","author":"G Grassi","year":"2023","unstructured":"Grassi G, Cuspidi C, Dell\u2019Oro R, Quarti-Trevano F. Diagnostic and therapeutic approach to different hypertensive phenotypes according to the 2023 ESH guidelines. High Blood Press Cardiovasc Prev. 2023;32:275\u201385. https:\/\/doi.org\/10.1007\/s40292-025-00716-x.","journal-title":"High Blood Press Cardiovasc Prev"},{"key":"786_CR10","doi-asserted-by":"publisher","unstructured":"Grassi G, Ram CVS, Palatini P.Am J Cardiol. 2025 Dec 1;256:155-160. https:\/\/doi.org\/10.1016\/j.amjcard.2025.09.022","DOI":"10.1016\/j.amjcard.2025.09.022"},{"key":"786_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2018.14","volume":"4","author":"S Oparil","year":"2018","unstructured":"Oparil S, Acelajado MC, Bakris GL, Berlowitz D, Cifkowa R, Dominiczack AF, et al. Hypertension. Nat Rev Dis Primers. 2018;4:18014. https:\/\/doi.org\/10.1038\/nrdp.2018.14.","journal-title":"Nat Rev Dis Primers"},{"key":"786_CR12","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1097\/HJH.0b013e32832e9500","volume":"27","author":"A Zanchetti","year":"2009","unstructured":"Zanchetti A. Bottom blood pressure or bottom cardiovascular risk? How far can cardiovascular risk be reduced? J Hypertens. 2009;27:1509\u201320. https:\/\/doi.org\/10.1097\/HJH.0b013e32832e9500.","journal-title":"J Hypertens"},{"key":"786_CR13","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1161\/Hypertensionaha.123.22610","volume":"81","author":"E Manta","year":"2024","unstructured":"Manta E, Thomopoulos C, Kariori M, Polyzos D, Mihas C, Konstantinidis D, et al. Revisiting cardiovascular benefits of blood pressure reduction in primary and secondary prevention: focus on targets and residual risk - A systematic review and meta-analysis. Hypertension. 2024;81:1076\u201386. https:\/\/doi.org\/10.1161\/Hypertensionaha.123.22610.","journal-title":"Hypertension"}],"container-title":["High Blood Pressure & Cardiovascular Prevention"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40292-026-00786-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40292-026-00786-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40292-026-00786-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T05:42:56Z","timestamp":1780119776000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40292-026-00786-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,18]]},"references-count":13,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["786"],"URL":"https:\/\/doi.org\/10.1007\/s40292-026-00786-5","relation":{},"ISSN":["1179-1985"],"issn-type":[{"value":"1179-1985","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,18]]},"assertion":[{"value":"17 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the Authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}